ArticlePloS one2026
Dual regulatory effects of medical bovine collagen sponge on macrophages in vitro.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medical bovine collagen sponges (MBCS) are extensively utilized in clinical settings for hemostasis and tissue augmentation owing to their superior biocompatibility, biodegradability and hemostatic properties. Nevertheless, their immunomodulatory influence on macrophage function remains largely unexplored. In this study, we systematically evaluated the effects of MBCS on RAW264.7 macrophages through comprehensive in vitro assays, including proliferation analysis, phagocytosis assessment, cytokine expression and angiogenesis evaluation. Our results demonstrate that MBCS significantly enhances macrophage proliferation and phagocytic capacity while potently stimulating VEGF secretion. Furthermore, MBCS-conditioned macrophage supernatants markedly promote endothelial tubule formation in vitro. Notably, MBCS moderately promotes inflammatory responses in resting macrophages, whereas pretreatment with MBCS effectively inhibits lipopolysaccharide (LPS)-induced pro-inflammatory reactions, as reflected by reduced production of TNF‑α, nitric oxide and CD86. These findings reveal the effects of MBCS on macrophages at the cellular level, providing experimental evidence and mechanistic support for its tissue-repairing functions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.